It was demonstrated that taVNS inhibited the expression of interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α), and promoted the functional recovery of cerebral ischemia/reperfusion-injured rats (Dash et al., 2022; Zhao et al., 2022). This evidence concerns the gene TNF and Cerebral ischemia.